III Gp Limited Partnership Ahls serves as Executive at Aegerion Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, III Gp Limited Partnership Ahls has executed 13 insider transactions totaling $7.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 9, 2012 involved selling 98,897 shares valued at $1.6M.
III Gp Limited Partnership Ahls currently holds 2,430,765 shares of Aegerion Pharmaceuticals, Inc. (AEGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, III Gp Limited Partnership Ahls has been a net seller of AEGR stock. They have purchased $2.5M and sold $5.1M worth of shares.
III Gp Limited Partnership Ahls's most recent insider trade was on Mar 9, 2012, when they sold 98,897 shares at $15.87 per share.
Get notified when new Form 4 filings are submitted
| $17.10 |
| Discretionary |
| Jan 30, 2012 | AEGR | $45.6K | Sale | 2,670 | $17.06 | Discretionary |
| Jan 27, 2012 | AEGR | $849.0K | Sale | 49,448 | $17.17 | Discretionary |
| Dec 9, 2011 | AEGR | $296.7K | Sale | 17,567 | $16.89 | Discretionary |
| Dec 8, 2011 | AEGR | $41.8K | Sale | 2,472 | $16.90 | Discretionary |
| Dec 6, 2011 | AEGR | $93.3K | Sale | 5,504 | $16.96 | Discretionary |
| Jul 29, 2011 | AEGR | $74.1K | Sale | 5,069 | $14.61 | Discretionary |
| Jun 29, 2011 | AEGR | $1.8M | Sale | 120,928 | $14.61 | Discretionary |
| Oct 27, 2010 | AEGR | $6.1M | Conversion | 805,140 | $7.60 | Discretionary |
| Oct 27, 2010 | AEGR | $0 | Conversion | 1,249,350 | $N/A | Discretionary |
| Oct 27, 2010 | AEGR | $0 | Conversion | 436,498 | $N/A | Discretionary |
| Oct 27, 2010 | AEGR | $2.5M | Purchase | 260,263 | $9.50 | Discretionary |